Results 21 to 30 of about 2,002,341 (191)

YTTRIUM-90 MICROSPHERE RADIOEMBOLIZATION FOR UNRESECTABLE CHOLANGIOCARCINOMA

, 2015
The term radioembolization defines those procedures in which intra-arterially injected radioactive microspheres are used for internal radiation purposes. The aim of this procedure is to selectively target radiation to liver tumors and to limit the dose to the normal liver parenchyma.
Cristina Mosconi, Matteo Renzulli, Federica Ciccarese, Rita Golfieri   +3 more
core   +3 more sources

Extrahepatic Applications of Yttrium-90 Radioembolization. [PDF]

Semin Intervent Radiol, 2021
AbstractWhile initially described and now accepted as treatment for primary and secondary malignancies in the liver, radioembolization therapy has expanded to include treatment for other disease pathologies and other organ systems. Advantages and limitations for these treatments exist and must be compared against more traditional treatments for these ...
Murali N, Mouli SK, Riaz A, Lewandowski RJ, Salem R.   +4 more
europepmc   +3 more sources

Prolonged Radiation-Induced Gastritis Following Yttrium-90 Radioembolization: A Case of Persistent Dyspepsia and Endoscopic Surveillance. [PDF]

Cureus
Yttrium-90 (Y-90) transarterial radioembolization (TARE) is an established therapy for unresectable hepatic malignancies. Although generally safe, Y-90 therapy can occasionally lead to extrahepatic complications, including gastrointestinal injury.
Latif MH, Gadallah A, Kang A, El-Halawani H, Sen S.   +4 more
europepmc   +2 more sources

Radioembolization for hepatocellular carcinoma: what clinicians need to know [PDF]

Journal of Liver Cancer, 2022
Transarterial radioembolization (TARE) with yttrium 90 (90Y) has been used in the management of hepatocellular carcinoma (HCC) for more than 10 years in Korea.
Jin Woo Choi, Hyo-Cheol Kim
doaj   +1 more source

Role of Yttrium-90 Radioembolization for Colorectal Hepatic Metastasis. [PDF]

Korean J Radiol, 2022
Kim HC.
europepmc   +4 more sources

Combination of transarterial radioembolization with atezolizumab and bevacizumab for intermediate and advanced staged hepatocellular carcinoma: A preliminary report of safety and feasibility

Journal of Interventional Medicine, 2023
Purpose: The IMbrave150 Phase III trial demonstrated the superiority of atezolizumab and bevacizumab (Atezo/Bev) over sorafenib for unresectable hepatocellular carcinoma (HCC).
Qian Yu, Yating Wang, Ethan Ungchusri, Mikin Patel, Divya Kumari, Thuong Van Ha, Anjana Pillai, Chih-yi Liao, Osman Ahmed   +8 more
doaj   +1 more source

Transarterial radioembolization for liver tumors as neoadjuvant therapy: three case reports

Einstein (São Paulo), 2020
Transarterial radioembolization (TARE) with yttrium-90 microspheres is a palliative locoregional treatment, minimally invasive for liver tumors. The neoadjuvant aim of this treatment is still controversial, however, selected cases with lesions initially ...
Vithor de Oliveira Carvalho, Francisco Leonardo Galastri, Breno Boueri Affonso, Priscila Mina Falsarella, Leonardo Guedes Moreira Valle, Ben-Hur Ferraz-Neto, Marcelo Bruno de Rezende, Joaquim Maurício da Motta-Leal-Filho, Rodrigo Gobbo Garcia, Felipe Nasser   +9 more
doaj   +2 more sources

Single-Compartment Dose Prescriptions for Ablative ⁹⁰Y-Radioembolization Segmentectomy

Life, 2023
Background: Yttrium-90 (90Y) radioembolization is increasingly being utilized with curative intent. While single-compartment doses with respect to the perfused volume for the complete pathologic necrosis (CPN) of tumors have been reported, the actual ...
Srinivas Cheenu Kappadath, Benjamin P. Lopez   +1 more
doaj   +1 more source

A Comparison of Techniques for 90Y PET/CT Image-Based Dosimetry following Radioembolization with Resin Microspheres

Frontiers in Oncology, 2014
90Y PET/CT following radioembolization has recently been established as a viable diagnostic tool, capable of producing images that are both quantitative and have superior image quality than alternative 90Y imaging modalities.
Alexander Samuel Pasciak, Alexander Samuel Pasciak, Austin C Bourgeois, Yong C Bradley   +3 more
doaj   +1 more source

Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma [PDF]

Gastrointestinal Tumors, 2020
<b><i>Purpose:</i></b> To report outcomes of transarterial radioembolization (TARE) using glass microspheres for the treatment of mixed hepatocellular-cholangiocarcinoma (HCC-CC) in a propensity-matched study. <b><i>Material and Methods:</i></b> Between 2013 and 2019, 10 consecutive patients with ...
Wali, Badar, Thuong, Van Ha, Steven, Zangan, Rakesh, Navuluri, Anjana, Pillai, Talia, Baker, Osman, Ahmed   +6 more
openaire   +2 more sources